Myeloablative allogeneic transplantation for chronic lymphocytic leukemia (CLL).
| No. of Patients . | TRM . | Severe GVHD . | Ongoing CR . | Median FU (months) . | Ref . |
|---|---|---|---|---|---|
| Abbreviations: TRM, treatment-related mortality; GVHD, graft-versus-host disease; CR, complete remission; FU, follow-up; DLI, donor lymphocyte infusion | |||||
| 54 | 25 | 18 | 24 | 27 | 40 |
| 15 | 5 | 26 | 8 | 35 | 44 |
| 23 | 8 | 47 | 14 | 24 | 42 |
| 25 | 7 | 56 | 9 | 60 | 43 |
| 25 | 1 early 5 late | 5 | 13 8 after DLI | 78 | 36 |
| No. of Patients . | TRM . | Severe GVHD . | Ongoing CR . | Median FU (months) . | Ref . |
|---|---|---|---|---|---|
| Abbreviations: TRM, treatment-related mortality; GVHD, graft-versus-host disease; CR, complete remission; FU, follow-up; DLI, donor lymphocyte infusion | |||||
| 54 | 25 | 18 | 24 | 27 | 40 |
| 15 | 5 | 26 | 8 | 35 | 44 |
| 23 | 8 | 47 | 14 | 24 | 42 |
| 25 | 7 | 56 | 9 | 60 | 43 |
| 25 | 1 early 5 late | 5 | 13 8 after DLI | 78 | 36 |